0001415889-24-000817.txt : 20240108
0001415889-24-000817.hdr.sgml : 20240108
20240108175012
ACCESSION NUMBER: 0001415889-24-000817
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240108
DATE AS OF CHANGE: 20240108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brockstedt Dirk G.
CENTRAL INDEX KEY: 0001635616
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 24521267
MAIL ADDRESS:
STREET 1: C/O ADURO BIOTECH, INC.
STREET 2: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
form4-01082024_100105.xml
X0508
4
2024-01-05
0001673772
RAPT Therapeutics, Inc.
RAPT
0001635616
Brockstedt Dirk G.
C/O RAPT THERAPEUTICS, INC.
561 ECCLES AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CHIEF SCIENTIFIC OFFICER
0
Common Stock
2024-01-05
4
S
0
898
22.78
D
27820
D
These shares were sold solely to pay taxes due upon vesting of the Restricted Stock Units granted on January 30, 2020 for 8,000 shares.
Includes 1,646 shares and two shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on April 28, 2023 and October 31, 2023, respectively.
/s/ Rodney Young, Attorney-in-Fact
2024-01-08